The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 24, 2021
Filed:
Sep. 07, 2017
Applicant:
Trustees of Tufts College, Medford, MA (US);
Inventors:
William W. Bachovchin, Cambridge, MA (US);
Hung-sen Lai, Andover, MA (US);
Wengen Wu, Winchester, MA (US);
Assignee:
Trustees of Tufts College, Medford, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/402 (2006.01); A61K 31/69 (2006.01); A61K 45/06 (2006.01); A61K 39/39 (2006.01); A61P 37/04 (2006.01); A61P 35/00 (2006.01); A61K 31/4025 (2006.01); A61K 31/4035 (2006.01); A61K 31/4439 (2006.01); A61K 35/13 (2015.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/402 (2013.01); A61K 31/4025 (2013.01); A61K 31/4035 (2013.01); A61K 31/4439 (2013.01); A61K 31/69 (2013.01); A61K 35/13 (2013.01); A61K 39/39 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); A61P 37/04 (2018.01); A61K 2039/505 (2013.01);
Abstract
Disclosed are combination therapies including administration of I-DASH inhibitors and PGE2 antagonists, and the use of such therapies in the treatment of cell proliferative diseases.
Bachovchin, William. (2021). Combination therapies using immuno-dash inhibitors and pge2 antagonists (U.S. Patent No. 11096924). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11096924
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile